XT2-12804-67212
3 vaccinations
4 coded responses
25 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 984 / WA
- Registered
- 2022-06-22
- Relationship
- Child or adolescent in my care
- Guardian
- CTG-85676-91481
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Registered in v-safe
-
2022-06-22
Dose 1 — Moderna
-
2022-06-22
Health check-in — day 0, dose 1, under 3Feeling: Good · Site: Pain, Swelling/hardness · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-23
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain, Swelling/hardness · Fever · NoneUnder 3 check-in
-
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · Irritability/cryingUnder 3 check-in
-
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-06-26
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Pruritus, Rash — Feeling: Good · Site: Pain, RednessFree text: Itching and localized rashMedDRA releases: 2024-11 · check-in free text available
- 2022-06-29
- 2022-07-07
- 2022-07-13
-
2022-07-20
Dose 2 — Moderna
-
2022-07-21
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Heart rate increased, Hypopnoea, Office visit — Feeling: Poor · Site: Pain · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Systemic reaction (other): Shallow breathing, fast heartbeat · Healthcare visit (other): PediatricianMedDRA releases: 2024-11 · check-in free text available
-
2022-07-21
Report sent to call center — days 1–6 daily, dose 2, under 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-22
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-07-22
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-23
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Site: Pain · Sleepiness, Loss of appetiteUnder 3 check-in
- 2022-07-25
- 2022-07-27
- 2022-08-03
- 2022-08-26
- 2022-10-19
-
2023-01-14
Dose 3 — Moderna
- 2023-01-18
-
2023-01-18
Health check-in — days 1–6 daily, dose 3, under 3Feeling: Good · Site: Redness · NoneUnder 3 check-in
- 2023-01-19
- 2023-01-20
- 2023-01-21
- 2023-01-29
-
2023-02-11
Survey response — day 28, dose 3, under 3MedDRA: Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-02-11
Report sent to call center — day 28, dose 3, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-02-13
- 2023-02-18
-
2023-02-27
Survey response — day 42, dose 3, under 3MedDRA: Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-02-27
Report sent to call center — day 42, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2023-02-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-02-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-20 | Moderna | No |
| 3 | 2023-01-14 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Itching and localized rash
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Shallow breathing, fast heartbeat
Healthcare visit (other): Pediatrician
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Heart rate increased | · | · | ✓ |
| SRO | Hypopnoea | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release